Introduction {#S0001}
============

Leishmaniasis and trypanosomiasis are arthropod-borne diseases of humans and animals caused by infection with protozoan hemoflagellates of the genus *Leishmania* and *Trypanosoma*, respectively. The two genera are incorporated into the family Trypanosomatidae, order Kinetoplastida. The most recent information released by the World Health Organization (WHO) shows that the extraordinary efforts at control, implemented at the peak of the epidemic in the early 2000s is reducing the number of new cases of HAT[@CIT0001] However, HAT has been close to eradication half a century before now, and the subsequent discontinuation of control programs allowed the disease to re-emerge to epidemic levels throughout Africa, which had then to be combatted with the same drugs that were introduced in the 1930s and before.[@CIT0002],[@CIT0003] Combination of nifurtimox and eflornithine (NECT) is presently suggested for the treatment of the late stage HAT because NECT treatment is simpler, safer, shorter and less expensive than single-agent eflornithine (DFMO)[@CIT0004] Moreover, animal trypanosomiasis is a very important disease of livestock causing billions of dollars in economic damage and spreading from Africa to areas from South America to East Asia[@CIT0005]

Leishmaniasis is caused by approximately 20 *Leishmania* species, which are transmitted by phlebotomine sandflies.[@CIT0006],[@CIT0007] According to the World Health Organization (WHO) around 1 million new cases, which cause around 30,000 deaths, occur every year around the world, mostly in the tropics or sub-tropics. The disease is still spreading geographically and is far from being controlled, due in large part to ecological and climate changes, and affects predominantly poor populations but, increasingly also eastern and southern Europe.[@CIT0008],[@CIT0009] Among individual infectious diseases as the ninth largest disease burden, leishmaniasis should not be overlooked in deliberations of tropical disease urgencies.[@CIT0010],[@CIT0011]

In recent years new α,β-unsaturated carbonyl-based compounds have been extensively investigated as multifunctional drug candidates. Previously we synthesized and evaluated several series of such compounds for anti-inflammatory,[@CIT0012] anticancer,[@CIT0013],[@CIT0014] immunomodulatory[@CIT0015],[@CIT0016] and anti-Alzheimer,[@CIT0017],[@CIT0018] identifying potent activities. Here, we have selected a series of such α,β-unsaturated carbonyl-based compounds for evaluation of their effects against a number of *Leishmania* and *Trypanosoma* strains including the well-characterized multi-drug resistant *Trypanosoma brucei* clonal line B48, which displays very high levels resistance to the two major classes of trypanocides, the diamidines and the melaminophenyl arsenicals, due to the loss of HAPT1 and TbAT1/P2 drug transporters[@CIT0019]

Materials and methods {#S0002}
=====================

Materials {#S0002-S2001}
---------

Synthetic α,β-unsaturated carbonyl-based compounds with cyclohexanone, 4-piperidone or tetrahydro-4-pyranone moiety were synthesized (Scheme 1), characterized and reported by us previously[@CIT0020] Stock solutions were prepared for each tested compound and diluted with complete medium for antiparasite testing, ensuring that the final DMSO concentration did not exceed 1% in the final conditions. Eflornithine (Sigma-Aldrich Ltd., Gillingham, UK) and pentamidine (Sigma-Aldrich Ltd., Gillingham, UK), the most widely used drugs for the treatment of HAT were selected as positive control.

Cell culture {#S0002-S2002}
------------

### Trypanosoma brucei bloodstream forms (BSF) in-vitro {#S0002-S2002-S3001}

The selected compounds were tested on bloodstream forms of two strains of *Trypanosoma brucei*: a standard drug-sensitive wild-type strain of *Trypanosoma brucei brucei* (Lister s427-WT) and B48, which was adapted from the clone TbAT1-KO by deletion of the TbAT1 drug transporter,[@CIT0021] itself derived from s427WT by removal of the *TbAT1* gene,[@CIT0021] by prolonged exposure to pentamidine in vitro[@CIT0019] Thus, these cells have neither TbAT1/P2 transporter nor the high affinity-pentamidine transporter (HAPT1) genes.[@CIT0019],[@CIT0022] Both strains were cultured in HMI-9 medium (pH 7.4) supplemented with 10% heat-inactivated Fetal Calf Serum (FCS, BioSera) and 14 µl/L of 13.4 M β-mercaptoethanol (Sigma), as described by Hirumi and Hirumi[@CIT0023] In a flow cabinet through filtration medium was sterilized. *T. b. brucei* cultures were incubated at 37 ºC and 5% CO~2~ and passaged in vented flasks three times a week.

### Leishmania major and leishmania mexicana promastigotes {#S0002-S2002-S3002}

*Leishmania major* strain Friedlin (LmjF) and *Leishmania mexicana* (strain MNYC/BZ/62/M379) were cultured in essential medium (HOMEM) and 10% FCS, pH 7.4, in plastic flasks at 25 °C. The cultures were passed to fresh medium three times per week, exactly as described previously[@CIT0024]

### Alamar blue assay {#S0002-S2002-S3003}

Resazurin (Alamar Blue) is commonly used as a metabolic function indicator. It is a non-fluorescent, blue dye that is mixed with cell cultures containing various drug concentrations, to determine the sensitivity of African trypanosomes or *Leishmania* cultures to the test compounds in vitro.[@CIT0025],[@CIT0026] Living cells metabolize the resazurin to red and fluorescent resorufin. Preparation of Alamar Blue reagent involves the dissolution of 12.5 milligrams of Resazurin sodium salt (Sigma) in 100 mL of phosphate-buffered saline (PBS) of pH 7.4, which is then filter-sterilized and stored in the dark at 4 ºC. For *T. b. brucei* bloodstream forms the assays were performed as described[@CIT0027] in 96-well plates with 1 × 10^5^ cell/well in the presence of 23 doubling dilutions of test compound, and one well for each dilution series receiving growth medium only, for 48 h at 37 °C/5% CO~2~. The Alamar blue solution was added for a further 24 h incubation before fluorescence was measured in a FLUOstar Optima plate reader (BMG Labtech, Durham, NC, USA), λ~ex~ 540 nm, λ~em~ 590 nm. EC~50~ values were calculated by non-linear regression to a sigmoidal curve with variable slope using Prism 5.0 (GraphPad Software Inc., San Diego, CA, USA). For *Leishmania* promastigotes the procedure was slightly adapted[@CIT0024] and the final density was 1 × 10^6^ cell/well with the initial incubation for 72 h followed by incubation with Alamar blue for 48 h as total of 120 h. All assays were repeated at least 3 times independently and each were positively controlled with pentamidine and eflornithine.

Results and discussion {#S0003}
======================

In the present study, the effect of synthetic α,β-unsaturated carbonyl-based compounds on the growth of promastigotes of *L. major, L. mexicana and different strains of Trypanosoma brucei brucei was evaluated* in vitro. Structures of all tested compounds are shown in [Table 1](#T0001){ref-type="table"} while the antitrypanosomal and leishmanicidal activities of compounds are shown in [Table 2](#T0002){ref-type="table"}.Table 1Structures of synthetic α,β-unsaturated carbonyl based compounds (cyclohexanone, tetrahydro-4-pyranone scaffold and 4-piperidone derivatives)![](DDDT-13-1179-i0001.jpg){#ILF0001}**No.CompoundR~1~Rʹ~4~Rʹ~3~Rʹ~1~3a**CH~2~HHCl**3b**CH~2~HOCH~3~Cl**3c**CH~2~OCH~3~OCH~3~Br**3d**![](DDDT-13-1179-i0002.jpg){#ILF0002}HHCl**3e**![](DDDT-13-1179-i0003.jpg){#ILF0003}HOCH~3~Cl**3f**![](DDDT-13-1179-i0004.jpg){#ILF0004}OCH~3~OCH~3~Br**3g**![](DDDT-13-1179-i0005.jpg){#ILF0005}HHCl**3h**![](DDDT-13-1179-i0006.jpg){#ILF0006}HOCH~3~Cl**3i**![](DDDT-13-1179-i0007.jpg){#ILF0007}OCH~3~OCH~3~Br**3j**NHHHCl**3k**NHHOCH~3~Cl**3l**NHOCH~3~OCH~3~Br**3m**![](DDDT-13-1179-i0008.jpg){#ILF0008}HHCl**3n**![](DDDT-13-1179-i0009.jpg){#ILF0009}HOCH~3~Cl**3o**![](DDDT-13-1179-i0010.jpg){#ILF0010}OCH~3~OCH~3~Br**3p**![](DDDT-13-1179-i0011.jpg){#ILF0011}HHCl**3q**![](DDDT-13-1179-i0012.jpg){#ILF0012}HOCH~3~Cl**3r**![](DDDT-13-1179-i0013.jpg){#ILF0013}OCH~3~OCH~3~Br**3s**OHHCl**3t**OHOCH~3~Cl**3u**OOCH~3~OCH~3~Br Table 2Effect of α,β-unsaturated carbonyl based compounds on *Trypanosoma brucei brucei* bloodstream forms and *Leishmania mexicana and Leishmania major* strainsCompounds*Trypanosoma brucei brucei bloodstream forms*\
EC~50~ (µM)*Leishmania* promastigotes\
EC~50~ (µM)WTB48*L. majorL. mexicana***3a**2.81±0.715.70±0.6612.13±1.6710.03±0.67**3b**17.92±1.1223.42±2.3419.36±4.0615.32±2.44**3c**\>100\>100\>100\>100**3d**\>10091.95±3.10\>100\>100**3e**4.35±0.154.45±0.09\>100\>100**3f**\>100\>100\>100\>100**3g**35.93±1.0131.49±0.37\>100\>100**3h**\>100\>100\>100\>100**3i**\>100\>100\>100\>100**3j**\>100\>100\>100\>100**3k**5.59±0.088.47±0.7941.55±2.46\>100**3l**\>100\>100\>100\>100**3m**\>100\>100\>100\>100**3n**15.15±1.6011.60±0.62\>100\>100**3o**1.83±0.061.75±0.053.02±0.104.12±0.69**3p**7.94±0.247.47±0.0916.85±2.8025.57±4.93**3q**\>100\>100\>100\>100**3r**17.36±2.758.22±1.20\>100\>100**3s**3.36±0.593.55±0.1810.56±0.9622.63±0.75**3t**4.12±0.124.04±0.114.89±0.426.37±0.36**3u**10.27±2.156.66±0.6738.40±8.6989.04±3.95Eflornithine19.47±2.4522.60±1.13\--Pentamidine0.005±0.0000.37±0.014.34±0.171.25±0.11[^1][^2]

Antitrypanosomal activity {#S0003-S2001}
-------------------------

In vitro trypanocidal properties of synthetic α,β-unsaturated carbonyl-based compounds were assessed for two different types of *Trypanosoma brucei brucei* where one was WT and second was the highly resistant *T. b. brucei* clonal line B48 ([Table 2](#T0002){ref-type="table"}). In this assay, reference drugs eflornithine and pentamidine were used as positive controls. Pentamidine was found very potent with EC~50~=0.005 µM for wild type and 0.37µM for clonal line B48 (*P*\<0.001), while EC~50~=19.47 and 22.6 uM were determined for eflornithine-treated WT and B48 (*P*\>0.05) parasites, respectively. Among the tested compounds, twelve derivatives inhibited both strains, with EC~50~ values within 2-fold different for the two strains, as compared to a 74-fold (increase) difference for pentamidine, showing that this class of compounds is not cross-resistant with diamidines and melaminophenyl arsenicals (Bridges et al, 2007). The highest inhibitory activity was exhibited by **3o** (EC~50~=1.7 µM) for clonal line B48 and second most strong inhibitor was synthetic compound **3a** with an EC~50~ value of 2.8 µM, closely followed by **3s** showing inhibition with an EC~50~ of 3.55 µM.

An interesting structure-activity relationship was observed for synthetic α,β-unsaturated carbonyl-based derivatives. Based on their chemical structure all 21 compounds can be divided into seven main groups, with three compounds in each group. Seven groups are suggested on the basis of R~1~ substitution in the central ring that linked the two substituted 3-methoxybenzene moieties. In each of the 7 groups the aromatic ring substitutions R~1~ʹ, R~3~ʹ, R~4~ʹ were kept the same \[(i) H/H/Cl; (ii) H/OCH~3~/Cl; (iii) OCH~3~/OCH~3~/Br\], allowing direct deduction of the role of the central ring modifications for each set of aromatic ring substitutions.

It is immediately clear that the R~1~ position substitution in the central linker played a vital part in the biological properties of these types of compounds, as we have previously reported for anti-inflammatory activities[@CIT0028] However, in the case of anti-inflammatory and anticancer activities[@CIT0020] different substitutions correlated with highest potency.

All three compounds with a tetrahydro-4-pyranone linker, **3s, 3t** and 3**u**, exhibited good activity, meaning that oxygen at the R~1~ position was favorable for activity against both strains of *T. b. brucei*. Within this group, **3s** displayed the highest activity, indicating that addition of Rʹ~3~ and Rʹ~4~ methoxy groups were not favored with this central ring. Among the other six linkers, the one with N-CH~3~ at R~1~ (**3m-3o**) exhibited the strongest trypanocidal activity and **3o** was the most active compound in the entire series (EC~50~(WT) =1.83±0.06). However, for the 1-methyl-4-piperidones the activity dramatically improved with the sequential addition of methoxy groups at Rʹ~3~ and Rʹ~4~, which appears to indicate that these compounds may have a different target than the tetrahydro-4-pyranones, where the methoxy groups had a deleterious effect. This notion is strengthened by the understanding that the tetrahydropyran oxygen is a strong H-bond acceptor, whereas the ring nitrogen of 1-methylpiperidone is unable to engage in similar H-bonding; similar reasoning can be applied to the methoxy substitution. Thus, the potential interactions of the most active compounds in these groups, **3s** and **3o**, respectively, with a cellular target would be very different, yet their trypanocidal activities are similar.

Indeed, the favorability of the methoxy substitutions appeared to differ depending on the identity of R~1~, probably because this influenced the 3D structure through the orientation/rotation of the aromatic rings relative to the central structure and each other ([Figure 1](#F0001){ref-type="fig"}). These observations mean that further extension of the SAR in this series should focus on one central group, optimizing the substituents on the aromatic rings, especially as the importance of the 2ʹ methoxy and the 1ʹ halogen for antitrypanosomal activity cannot be assessed from the current as they are present in all derivatives. However, the present data (1) reveal which central rings are optimal, (2) provide a limited SAR starting point for these scaffolds and (3) establish that even with the very limited exploration of this chemical space several trypanocides with EC~50~ values in the range 1--5 µM could be identified. This activity is obviously much superior to eflornithine ([Table 2](#T0002){ref-type="table"}) and close to that of the standard veterinary trypanocide diminazene aceturate as well[@CIT0021] Moreover, the α,β-unsaturated carbonyl-based compounds were not cross-resistant with diamidines and arsenical trypanocides as they displayed the same activities against the multi-drug resistant clone B48.Figure 1Energy-minimized 3D structures of compounds **3s** and **3o**, produced using Chem3D Ultra 10.0 (CambridgeSoft).

Antileishmanial activity {#S0003-S2002}
------------------------

The extracellular insect-infective promastigote form of *Leishmania* is addressed in many drug screening assays against *Leishmania* which can be performed readily, thus being additional suitable for automation even though the *Leishmania* parasite exists in the human host in its intra-macrophage amastigote form[@CIT0029] In the current study, all synthetic α,β-unsaturated carbonyl-based compounds were tested on promastigotes of *L. major* and *L. mexicana* ([Table 2](#T0002){ref-type="table"}). Eight synthetic compounds showed inhibition, with EC~50~ values in the range 3 to 41.5 µM for *L. major* and very similar activities against *L. mexicana*. The most active compound was again **3o (**EC~50~ 3.02±0.10 µM), which performed superior to the positive control pentamidine (EC~50~ 4.34±0.17 µM). The activity was generally below that displayed for *T. b. brucei* but in general the compounds most active against the trypanosome strains were also the most active against both *Leishmania* species (*mexicana & major*). In fact, we found very strong correlation between the trypanocidal and antileishmanial activity of these compounds, as **3a, 3b, 3o, 3p, 3s, 3t** and **3u** displayed activities against two trypanosoma strains as well as two distinct Leishmania species, and some compounds like **3c, 3f, 3h, 3i, 3j, 3m** and **3q** have no effect against any of the parasites. For antileishmanial activity, again tetrahydro-pyran-4-one backbone was found best inhibitor among all other linkers as all three compounds bearing this backbone were found to have various levels of activity - yet the best activity was by **3o**, with a 1-methyl 4-piperidone backbone.Scheme 1Synthesis scheme of α,β-unsaturated carbonyl-based compounds. Reagents and conditions: (**i**) NaOH, EtOH, room temperature.

Conclusion {#S0004}
==========

In this study some synthetic α,β-unsaturated carbonyl-based compounds with three types of substitution pattern and seven types of central linker have been identified with potential applications against trypanosomiasis and leishmaniasis. Total twenty-one derivatives were evaluated and twelve of them exhibited good trypanocidal and/or antileishmanial activities. The most promising results were obtained for compound **3o** that showed the best inhibition of *Trypanosoma brucei brucei* wild type (WT) as well as *T. b. brucei* clonal line B48 and strong activity against *Leishmania* promastigotes, exceeding the efficacy of the positive control. Further studies should be conducted to further explore the SAR and better understand the mechanism of action of these molecules. Thus, these series of new α,β-unsaturated carbonyl-based could be considered as promising hit compounds against leishmaniasis and trypanosomiasis requiring further hit optimization and safety evaluations.
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==========

The authors report no conflicts of interest in this work.

[^1]: **Notes:**All EC~50~ values were obtained using the Alamar blue assay and are given as averages in µM (±SEM), of 3 independent determinations.

[^2]: **Abbreviations:**WT, wild-type sensitive control strain; B48, multi-drug resistant clone.
